Policy and Advocacy Library

The Policy and Advocacy Library is the culmination of the collaborative work of RACP ​members and comprises a comprehensive range of evidence-based, published RACP position statements, policies and submissions.

Can’t find what you’re looking for?

Please email policy@racp.edu.au or use the online contact form.

How can I contribute my expertise?

RACP Trainees and Physicians need to see Represent Your Profession or email policy@racp.edu.au or use the online contact form.

Search results

Submission to Senate Inquiry on Tobacco Harm Reduction

Published
15 Jan 2021
Published in
Australia
Topic
e-cigarettes
Description
This submission to the Select Committee on Tobacco Harm Reduction provides evidence and recommendations on vaping in terms of its effectiveness as a smoking cessation aid; impact on overall smoking rates; potential gateway effects and renormalisation of smoking; and the vested interests of the tobacco industry. It also highlights the RACP’s policy position on vaping – that is a precautionary approach must be taken to access to nicotine e-cigarettes and must be confined to smokers who are unable to quit smoking as the treatment option of last resort

Submission to TGA consultation on interim decision in relation to nicotine

Published
15 Jan 2021
Published in
Australia
Topic
e-cigarettes
Description
This submission outlines the RACP’s response to the TGA’s proposed amendment to the nicotine scheduling as well as our concerns and recommendations over prescribing of non-TGA approved nicotine e-cigarettes. Comments on the ACCS-ACMS’s risk and benefit assessment of nicotine e-cigarettes are also contained in this submission.

Indigenous child health in Australia and Aotearoa New Zealand

Published
16 Dec 2020
Published in
New Zealand
Topic
Child health and young adult medicine
Description
The statement on Indigenous Child Health in Australia and Aotearoa New Zealand outlines Indigenous models of health, why the health of Indigenous children is different and the social determinants the underpin that, approaches to child health and case studies of paediatricians working with communities. The statement was developed by Australian and Aotearoa New Zealand paediatricians with key input from Māori and Aboriginal and Torres Strait Islander health organisations.

RACP Clinical Ethics Position Statement 2020

Published
15 Dec 2020
Published in
New Zealand
Topic
Ethics
Description
The RACP Clinical Ethics Position Statement (December 2020) recognises ethics as a fundamental part of health care and makes explicit the need for both education in clinical ethics for medical professionals, and for Clinical Ethics Support Services to be embedded within the health care systems of Australia and New Zealand. It advocates a more formalised approach to clinical ethics be adopted to better support practitioners in the contemporary health context.

RACP briefing to the incoming Minister of Health

Published
03 Dec 2020
Published in
New Zealand
Topic
Public health
Description
The RACP congratulates the incoming Minister on his appointment. We hope that we can work productively together towards achieving our #MakeItTheNorm goals and health equity in Aotearoa New Zealand.

RACP Submission: The Queensland Law Reform Commission’s legal framework for voluntary assisted dying

Published
27 Nov 2020
Published in
Qld, Australia
Topic
Euthanasia
Description
This submission on the Queensland Law Reform Commission’s legal framework for voluntary assisted dying is based on the RACP Statement on Voluntary Assisted Dying (VAD). The submission builds on the VAD-related section of the RACP’s previous submission to the Queensland Parliament inquiry into aged care, end-of-life and palliative care and voluntary assisted dying of April 2019. The submission discusses a number of issues most relevant to the College’s remit and expertise. However, it is important to note that the existence of divergent member views constrains the RACP from developing a single position on the legalization VAD and precludes the College from engaging in discussing the eligibility criteria or processes for VAD, beyond emphasizing the need for strong, appropriately implemented safeguards to protect potential participants in any such scheme.

RACP Submission: National Dust Disease Taskforce_Second Consultation

Published
17 Nov 2020
Published in
Australia
Topic
Occupational and environmental health
Description
This submission to the Australian National Dust Disease Taskforce’s second consultation was led by the College’s Australasian Faculty of Occupational and Environmental Medicine (AFOEM). It makes the following key recommendations to address the prevention, early identification, control and management of dust diseases of accelerated silicosis and other occupationally-acquired dust diseases: - Establishment of a licensing scheme - Implementation of a national dust disease registry - More involvement of occupational and environmental medicine physicians and other medical specialists in the whole process - Increased and improved health and workplace monitoring.

RACP Submission: Actuaries Institute Disability Insurance Taskforce - Feedback

Published
04 Nov 2020
Published in
Australia
Topic
Occupational and environmental health
Description
This submission focuses specifically on aspects of the Taskforce’s review into individual disability income insurance that are most relevant to the knowledge and expertise of physicians. Its stresses the need for an increased focus on early intervention, the use of multi-disciplinary assessments for complex cases and the important skills occupational and environmental physicians and rehabilitation medicine physicians have in assessing occupational disability and fitness for work

RACP Submission: NSW Government consultation – Independent Review of Insurance and Care NSW

Published
04 Nov 2020
Published in
NSW, Australia
Topic
Public health
Description
This submission focuses on how the New South Wales’ workers’ compensation system can produce better health outcomes for workers injured at work by putting the health of workers at the centre of the NSW workers’ compensation scheme by adopting evidence-based treatment and care and emphasising prevention of injury; focusing on early timely and proactive claims management and utilising the expertise of specialist physicians

COVID-19: Guidance on workplace risk management (updated 23/10/2020)

Published
23 Oct 2020
Topic
Occupational and environmental health
Description
The purpose of this document is to provide guidance on how to implement the principles of infection prevention and control with respect to the SARS-CoV-2 virus, using the hierarchy of controls, a commonly understood framework for managing workplace health and safety risks. This will assist workplaces to manage the risk of COVID-19 on similar terms as for any other workplace hazard.
Loading
Close overlay